Xu Cao Selected Research

Acids

1/2022	Lamprey immunity protein enables detection for bladder cancer through recognizing N-hydroxyacetylneuraminic acid (Neu5Gc)-modified as a diagnostic marker and exploration of its production mechanism.
7/2016	Protective Effect of Baicalin Against Experimental Colitis via Suppression of Oxidant Stress and Apoptosis.
1/2014	The diagnosis of diabetic acute complications using the glucose-ketone meter in outpatients at endocrinology department.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu Cao Research Topics

Disease

56	Neoplasms (Cancer) 05/2024 - 02/2002
26	Osteoarthritis 03/2024 - 06/2006
15	Inflammation (Inflammations) 12/2023 - 08/2013
14	Pain (Aches) 03/2024 - 10/2011
11	Osteoporosis 11/2021 - 04/2003
9	Breast Neoplasms (Breast Cancer) 12/2023 - 04/2003
8	Bone Resorption 10/2023 - 07/2009
6	Fibrosis (Cirrhosis) 01/2022 - 02/2008
5	Hypersensitivity (Allergy) 10/2023 - 04/2016
5	Parkinson Disease (Parkinson's Disease) 09/2023 - 05/2018
5	Neoplasm Metastasis (Metastasis) 06/2023 - 11/2015
5	Neuroblastoma 01/2023 - 12/2017
5	Cerebral Palsy (Spastic Diplegia) 04/2010 - 12/2008
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2024 - 01/2023
4	Infections 04/2024 - 09/2021
4	Non-alcoholic Fatty Liver Disease 01/2024 - 07/2015
4	Ischemia 12/2023 - 07/2010
4	Osteosarcoma (Osteogenic Sarcoma) 09/2023 - 08/2017
4	Intervertebral Disc Degeneration 06/2022 - 01/2017
4	Hypoxia (Hypoxemia) 02/2022 - 01/2007
4	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 01/2018 - 07/2009
3	Carcinogenesis 05/2024 - 03/2013
3	COVID-19 04/2024 - 09/2021
3	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2020
3	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 08/2023
3	Neuroinflammatory Diseases 12/2023 - 10/2018
3	Knee Osteoarthritis 12/2023 - 11/2019
3	Vascular Calcification 12/2023 - 06/2014
3	Disease Progression 12/2023 - 01/2021
3	Atherosclerosis 10/2023 - 01/2018
3	Chronic Hepatitis B 01/2023 - 01/2021
3	Body Weight (Weight, Body) 04/2019 - 01/2014
3	Rheumatoid Arthritis 01/2019 - 06/2006
3	Abdominal Aortic Aneurysm 08/2013 - 12/2012
3	Leukemia 08/2006 - 02/2005
2	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2024 - 11/2023
2	Pneumonia (Pneumonitis) 04/2024 - 12/2015
2	Intellectual Disability (Idiocy) 01/2024 - 10/2021
2	Chronic Pain 01/2024 - 09/2023
2	Kidney Diseases (Kidney Disease) 12/2023 - 01/2016
2	Reperfusion Injury 12/2023 - 06/2015
2	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2021
2	Low Back Pain (Lumbago) 11/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2005
9	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 02/2002
9	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 05/2005
6	Dinoprostone (PGE2)FDA Link 03/2024 - 12/2019
6	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 04/2012
6	Oxygen (Dioxygen)IBA 01/2021 - 07/2010
5	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 01/2023
5	Becaplermin (PDGF-BB)FDA Link 12/2023 - 11/2014
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 10/2022
5	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2014
5	RNA (Ribonucleic Acid)IBA 10/2022 - 02/2005
5	Estrogens (Estrogen)FDA Link 01/2022 - 04/2003
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2010
4	LipidsIBA 10/2023 - 02/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023 - 06/2006
4	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2005
4	Netrin-1IBA 03/2022 - 01/2019
4	Therapeutic UsesIBA 01/2022 - 12/2014
4	GlucocorticoidsIBA 01/2020 - 04/2003
4	Smad4 ProteinIBA 09/2006 - 05/2005
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 08/2023
3	AntioxidantsIBA 01/2024 - 08/2010
3	TransferasesIBA 01/2024 - 07/2015
3	LipopolysaccharidesIBA 12/2023 - 10/2012
3	Small Cytoplasmic RNAIBA 12/2023 - 01/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 11/2019
3	Acetic Acid (Vinegar)FDA LinkGeneric 09/2023 - 10/2011
3	polysulfideIBA 01/2023 - 01/2018
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2006
3	Neutralizing AntibodiesIBA 01/2022 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2014
3	AcidsIBA 01/2022 - 01/2014
3	Insulin-Like PeptidesIBA 12/2021 - 06/2013
3	SulfurIBA 01/2021 - 01/2018
3	CytokinesIBA 01/2021 - 11/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2015
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 05/2018
3	cathepsin SIBA 10/2018 - 12/2012
3	Dichlorodiphenyldichloroethane (DDD)IBA 01/2018 - 01/2016
3	NestinIBA 06/2014 - 06/2013
2	Retinaldehyde (Retinal)IBA 04/2024 - 12/2023
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2024 - 01/2023
2	Indicators and Reagents (Reagents)IBA 01/2024 - 12/2023
2	HDL CholesterolIBA 01/2024 - 11/2023
2	IronIBA 12/2023 - 10/2014
2	InflammasomesIBA 12/2023 - 03/2023
2	CreatinineIBA 12/2023 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 12/2023 - 02/2022
2	Parathyroid Hormone (Parathormone)IBA 11/2023 - 01/2021
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2023 - 03/2021

Therapy/Procedure

31	Therapeutics 04/2024 - 02/2014
7	Immunotherapy 09/2023 - 07/2018
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
3	Radiotherapy 01/2021 - 01/2020
2	Intra-Articular Injections 12/2023 - 01/2023
2	Neoadjuvant Therapy 12/2023 - 02/2022